Skip to main content

Web Exclusives

Ovarian Cancer, FDA Updates
October 28, 2019 – Oncology News & Updates
Read More
Breast Cancer, Multiple Myeloma, Pediatric Cancer, FDA Updates
Vincristine, Racial Disparities in Multiple Myeloma, and HER2 Metastatic Breast Cancer Are in the News
Read More
FDA Updates
FDA on In Vitro Diagnostics, Vaping; Cost of Novel Treatments
Read More
Multiple Myeloma, FDA Updates
FDA Approves Darzalex Combination for First-Line Treatment of Transplant-Eligible Patients with Multiple Myeloma
Read More
Renal-Cell Carcinoma
Avelumab plus Axitinib New First-Line Standard of Care in Advanced Renal-Cell Carcinoma
Chase Doyle
Read More
Lymphoma, FDA Updates
Polivy FDA Approved for Patients with Relapsed or Refractory DLBCL
Read More
Multiple Myeloma
Economic Implications of Inpatient versus Outpatient Autologous Transplant for Patients with Multiple Myeloma
Chase Doyle
Read More
Meeting Highlights
ASCO Highlights
FDA Unveils Pilot Program to Expand Access to Investigational Oncology Drugs
Phoebe Starr
Read More
Immunotherapy
CAR T-Cell Therapy Targeting Solid Tumors
Chase Doyle
Read More
FDA Updates
Keytruda Approved for Patients with Previously Treated Metastatic Small-Cell Lung Cancer
Yvette Florio Lane
Read More
Page 24 of 43
Results 231 - 240 of 425